MV Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.2K | Sell |
257
-48
| -16% | -$15.8K | 0.01% | 277 |
|
|
2025
Q4 | $107K | Buy |
305
+10
| +3% | +$3.38K | 0.01% | 238 |
|
|
2025
Q3 | $95.3K | Buy |
295
+4
| +1% | +$1.24K | 0.01% | 243 |
|
|
2025
Q2 | $113K | Sell |
291
-9
| -3% | -$3.62K | 0.01% | 230 |
|
|
2025
Q1 | $130K | Buy |
300
+17
| +6% | +$6.82K | 0.01% | 210 |
|
|
2024
Q4 | $104K | Sell |
283
-65
| -19% | -$27.2K | 0.01% | 225 |
|
|
2024
Q3 | $181K | Sell |
348
-31
| -8% | -$16.6K | 0.02% | 184 |
|
|
2024
Q2 | $205K | Buy |
379
+11
| +3% | +$5.81K | 0.02% | 167 |
|
|
2024
Q1 | $191K | Sell |
368
-1
| -0.3% | -$497 | 0.02% | 175 |
|
|
2023
Q4 | $174K | Buy |
369
+12
| +3% | +$5.55K | 0.02% | 170 |
|
|
2023
Q3 | $155K | Sell |
357
-3
| -0.8% | -$1.36K | 0.02% | 169 |
|
|
2023
Q2 | $160K | Sell |
360
-4
| -1% | -$1.84K | 0.02% | 170 |
|
|
2023
Q1 | $167K | Buy |
364
+2
| +0.6% | +$952 | 0.02% | 160 |
|
|
2022
Q4 | $186K | Buy |
362
+7
| +2% | +$3.55K | 0.03% | 133 |
|
|
2022
Q3 | $161K | Buy |
355
+31
| +10% | +$14.8K | 0.03% | 138 |
|
|
2022
Q2 | $156K | Buy |
324
+55
| +20% | +$27.2K | 0.03% | 142 |
|
|
2022
Q1 | $132K | Buy |
269
+185
| +220% | +$84.6K | 0.02% | 155 |
|
|
2021
Q4 | $39K | Buy |
84
+8
| +11% | +$3.37K | 0.01% | 240 |
|
|
2021
Q3 | $28K | Buy |
76
+33
| +77% | +$12.5K | ﹤0.01% | 267 |
|
|
2021
Q2 | $16K | Buy |
43
+37
| +617% | +$14.1K | ﹤0.01% | 307 |
|
|
2021
Q1 | $2K | Buy |
+6
| New | +$1.93K | ﹤0.01% | 299 |
|
|
2019
Q2 | – | Sell |
-14
| Closed | -$4K | – | 359 |
|
|
2019
Q1 | $4K | Hold |
14
| – | – | ﹤0.01% | 301 |
|
|
2018
Q4 | $4K | Hold |
14
| – | – | ﹤0.01% | 272 |
|
|
2018
Q3 | $4K | Hold |
14
| – | – | ﹤0.01% | 309 |
|
|
2018
Q2 | $3K | Hold |
14
| – | – | ﹤0.01% | 336 |
|
|
2018
Q1 | $3K | Hold |
14
| – | – | ﹤0.01% | 334 |
|
|
2017
Q4 | $3K | Hold |
14
| – | – | ﹤0.01% | 334 |
|
|
2017
Q3 | $3K | Hold |
14
| – | – | ﹤0.01% | 322 |
|
|
2017
Q2 | $3K | Buy |
+14
| New | +$2.52K | ﹤0.01% | 311 |
|
|
2015
Q3 | – | Sell |
-522
| Closed | -$86K | – | 309 |
|
|
2015
Q2 | $86K | Buy |
522
+219
| +72% | +$35K | 0.03% | 137 |
|
|
2015
Q1 | $47K | Buy |
303
+96
| +46% | +$13.7K | 0.02% | 172 |
|
|
2014
Q4 | $26K | Buy |
+207
| New | +$25.6K | 0.01% | 209 |
|
Other funds holding ELV
VCM
VPM
MV Capital Management's ELV Position: Q1 2026 in Review
MV Capital Management reduced its Elevance Health (ELV) stake by 16% in Q1 2026, selling an estimated $15.8K and leaving 257 shares worth $75.2K. The position accounts for 0.01% of the portfolio, ranked #277.
MV Capital Management first reported a position in ELV in Q4 2014 and has held it in 32 quarters since. The position peaked at $205K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- MV Capital Management held 257 shares of Elevance Health worth $75.2K as of Q1 2026.
- MV Capital Management sold 48 Elevance Health shares in Q1 2026, an estimated $15.8K.
- Elevance Health made up 0.01% of MV Capital Management's portfolio in Q1 2026, its #277 holding.
- MV Capital Management first reported a position in Elevance Health in Q4 2014 and has held it in 32 quarters since.
- MV Capital Management's Elevance Health position peaked at $205K in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.